阻断 CD19 CAR-T 细胞上的 CD30 增强其抗 B 细胞白血病/淋巴瘤的功能能力
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma.
67.9分
★★★☆☆
站内排序·非疗效
ALL SOURCES
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma.
CAR-T Cell Therapy for Classical Hodgkin Lymphoma.
Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders.
Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。